Xiamen University

Xiamen Innovax Biotech Co., Ltd.

Xiamen Innodx Biotech Co., Ltd.

Zuxing Weng

Shengxiang Ge

Feihai Xu

Liuwei Song

Xudong Sun

Jun Zhang

Ningshao Xia

Quan Yuan

Zimin Chen

Haijun Lin

Shunhua Wen

Wenbin Zhou

Junhui Xiong

Long Wang

Xiaohong Zheng

A kit for quantitatively detecting HBsAg and a method for quantitatively detecting an HBsAg content in a sample containing HBsAg. The kit comprises a first antibody specifically binding to HBsAg and a reagent composition. The reagent composition comprises tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and urea.

Kit and method for quantitative detection of HBsAg

The present invention relates to a method for quantitative detection of anti-HBc and its use in monitoring disease progression of chronic hepatitis B patients and predicting therapeutic effects. By quantitative detection of antibodies against hepatitis B core protein (Anti-HBc), it is able to monitor disease progression of chronic hepatitis B patients, effectively predict therapeutic effects in chronic hepatitis B patients who accept a therapy against hepatitis B virus (especially, a therapy based on interferon and a therapy based on nucleoside/nucleotide analog anti-HBV drug), and thus guide the patients to reasonably choose drugs.

Anti-HBc quantitative detection method and uses thereof in monitoring and controlling disease progression of chronic hepatitis B patient and in predicting therapeutic effect

Growing community of inventors

Xiamen, China

Zuxing Weng